封面
市場調查報告書
商品編碼
2088718

蛋白質結晶和晶體學市場:2026-2032年全球市場預測(按產品類型、技術、晶體類型、應用和最終用戶分類)

Protein Crystallization & Crystallography Market by Product Type, Technology, Crystal Type, Application, End User - Global Forecast 2026-2032

出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年,蛋白質結晶和晶體學市場將成長至 54.8 億美元,複合年成長率為 9.25%。

主要市場統計數據
基準年 2025 29.5億美元
預計年份:2026年 32.2億美元
預測年份 2032 54.8億美元
複合年成長率 (%) 9.25%

蛋白質結晶和晶體學在基於結構的藥物發現、生物工程、酶學和分子生物學中繼續發揮基礎作用。 X光晶體學持續提供高解析度原子模型,為製藥、生物技術、學術和政府實驗室中的先導化合物最佳化、標靶檢驗、基於片段的藥物發現和作用機制研究提供支援。

該領域的發展趨勢受到以下因素的影響:對精確3D蛋白質結構的持續需求、同步輻射光束線的日益普及、晶體篩檢方法的改進和自動化、微聚焦X光源以及配套計算工具的出現。蛋白質資料庫(PDB)在2023年實驗測定的結構數量突破了20萬個。這顯示全球結構生物學研究的規模之大,以及晶體學方法與冷凍電鏡、核磁共振波譜和基於人工智慧的蛋白質結構預測等技術並駕齊驅的持續重要性。

該領域的變革性變化

蛋白質結晶和晶體學領域正從手動、低通量的工作流程轉向自動化、數據豐富且小型化的平台。機器人液體處理系統、奈米升級分液、自動化成像系統、微流體技術以及改進的結晶試劑盒正在減少樣品消耗,並提高即使對於具有挑戰性的蛋白質靶標,也能找到可用結晶條件的可能性。

人工智慧的累積影響

人工智慧正在透過改進標靶優先排序、構建體設計、結晶條件選擇、衍射圖像分析、分子替換和模型純化等方法,重塑蛋白質結晶和晶體學領域。由DeepMind和EMBL-EBI開發的AlphaFold蛋白質結構資料庫提供了超過2億個預測的蛋白質結構,大大擴展了假設生成和分子替換策略的起點。

關鍵區域的洞察

在亞太地區,中國、日本、印度、韓國、澳洲和東南亞國協透過對同步輻射基礎設施、藥物研發和結構生物學能力的投資,正取得快速進展。該地區的這一發展勢頭得益於大規模的科研人才庫、不斷擴展的生物製藥和生物類似藥項目,以及諸如日本SPring-8、中國上海同步輻射裝置、韓國浦項加速器實驗室和澳大利亞同步輻射裝置等先進設施。北美地區繼續保持其領先地位,擁有活躍的生物製藥活動、美國國立衛生研究院(NIH)和國家科學基金會(NSF)資助的研究、成熟的受託研究機構(CRO),以及美國和加拿大的主要同步輻射設施,包括先進光子源(APS)、史丹佛同步輻射裝置(STSRF)、國家同步輻射裝置二期(NSRFC)和加拿大光源(NSRFC)。

關鍵小組洞察

隨著新加坡、泰國、馬來西亞、越南、印尼和菲律賓在生物技術教育、轉化研究、區域製藥生產和生物醫學研究領域不斷擴大夥伴關係,東協的重要性日益凸顯。海灣合作理事會(GCC)將生命科學定位為經濟多元化的重要組成部分,沙烏地阿拉伯、阿拉伯聯合大公國和卡達正在投資研究型大學、基因組學、醫療創新和生物醫學基礎設施,以滿足未來對結構生物學的需求。

主要國家的概況

美國透過生物製藥研發、聯邦研究津貼、國家實驗室以及同步輻射設施(例如先進光子源 (APS)、史丹佛同步輻射裝置 (SSRL)、國家同步輻射光源 II (NSLS II) 和先進光源 (ALS))來推動需求。加拿大透過其學術結構生物學網路、生物技術叢集和加拿大光源做出貢獻,而墨西哥則加強了製藥生產和大學主導的研究。巴西憑藉 LNLS 和 Sirius 同步輻射設施的能力,是拉丁美洲最重要的結構生物學市場。

為行業領導者提供的實用建議

產業領導者應將蛋白質結晶和晶體結構分析定位為綜合結構生物學中的一項策略能力,而不僅僅是有限的實驗室服務。優先事項應包括:實現結晶篩檢自動化、引入人工智慧驅動的構建體和條件選擇、改進實驗室數據管理,以及將X光晶體學與冷凍電鏡(cryo-EM)、生物物理學、質譜和計算化學相結合。

調查方法

本執行摘要採用系統化的二手資料調查方法編寫,重點在於檢驗的科學、機構和產業資訊來源。資訊來源包括公共資源,例如全球蛋白質資料庫 (Worldwide Protein Data Bank)、RCSB PDB 和 EMBL-EBI;同行評審的結構生物學文獻;政府研發津貼機構;同步輻射設施出版刊物;以及領先的製藥和生物技術公司的資訊披露。

結論

蛋白質結晶和晶體學在理解蛋白質功能和推動基於結構的藥物發現方面仍然發揮著至關重要的作用。雖然人工智慧驅動的預測和冷凍電鏡(cryo-EM)正在擴展結構生物學的工具箱,但晶體學對於實驗檢驗原子級細節、配體結合、溶劑相互作用、金屬配位和3D結構狀態仍然至關重要。

目錄

第1章:序言

第2章:調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣,2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章:人工智慧的累積影響,2026年

第7章:蛋白質結晶與晶體學市場:依產品類型分類

  • 裝置
    • 蛋白質結晶裝置
      • 液體處理系統
      • 納升分配系統
      • 微流體液體處理系統
      • 影像系統
      • 培養箱
    • 晶體學設備
      • X光繞射儀
      • 冷凍電鏡系統
      • 光束線設備
      • 同步輻射光束線
      • 微聚焦光束線
  • 消耗品
    • 結晶試劑
      • 緩衝溶液
      • 沉澱物
      • 添加劑
    • 結晶試劑盒
    • 盤子
      • 24孔盤
      • 96孔盤
      • 384孔盤
    • 密封系統
  • 軟體
    • 數據採集軟體
    • 視覺化軟體
    • 資料處理軟體
  • 服務
    • 蛋白質結晶服務
      • 篩檢服務
      • 最佳化服務
    • 結構決策服務
      • X光晶體結構分析服務
      • 冷凍電鏡(冷凍電子顯微鏡)服務
    • 諮詢服務

第8章:蛋白質結晶與晶體學市場:依技術分類

  • 電子晶體學
  • 中子晶體學

第9章:蛋白質結晶與晶體學市場:依晶體類型分類

  • 可溶性蛋白質晶體
  • 膜蛋白晶體
  • 蛋白質複合物晶體
  • 核酸複合物晶體

第10章:蛋白質結晶與晶體學市場:依應用領域分類

  • 藥物發現與開發
    • 基於結構的藥物發現設計
    • 基於片段的藥物研發
    • 先導藥物最適化
  • 材料科學
  • 結構生物學

第11章:蛋白質結晶與晶體學市場:依最終用戶分類

  • 學術研究機構
  • 受託研究機構
  • 製藥和生物技術公司

第12章 蛋白質結晶與晶體學市場:依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章:蛋白質結晶與晶體學市場:按組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 蛋白質結晶與晶體學市場:依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析,2025年
    • 濃度比(CR)
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析,2025 年
  • 2025年產品系列分析
  • 基準分析,2025 年

第16章:公司簡介

  • Agilent Technologies Inc
  • Anton Paar GmbH
  • Arinax Scientific Instrumentation
  • Art Robbins Instruments LLC
  • Bio Rad Laboratories Inc
  • BOC Sciences
  • Bruker Corporation
  • Calibre Scientific Inc
  • Charles River Laboratories International Inc
  • Corning Incorporated
  • Creative Biostructure
  • Danaher Corporation
  • Douglas Instruments Ltd
  • Emerald Biosystems Inc
  • Formulatrix Inc
  • Greiner Bio One International GmbH
  • Hampton Research Corp
  • Helix BioStructures LLC
  • HiMedia Laboratories Pvt Ltd
  • Jena Bioscience GmbH
  • Merck KGaA
  • Mettler Toledo International Inc
  • MiTeGen LLC
  • Molecular Dimensions Ltd
  • Proteros Biostructures GmbH
  • QIAGEN GmbH
  • Rigaku Holdings Corporation
  • SARomics Biostructures AB
  • Tecan Group Ltd
  • Thermo Fisher Scientific Inc
Product Code: MRR-591B7BD94C42

The Protein Crystallization & Crystallography Market is projected to grow by USD 5.48 billion at a CAGR of 9.25% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.95 billion
Estimated Year [2026] USD 3.22 billion
Forecast Year [2032] USD 5.48 billion
CAGR (%) 9.25%

Protein crystallization and crystallography remain foundational to structure-based drug design, biologics engineering, enzymology, and molecular biology. X-ray crystallography continues to provide high-resolution atomic models that support lead optimization, target validation, fragment-based drug discovery, and mechanistic studies across pharmaceutical, biotechnology, academic, and government laboratories.

The landscape is shaped by sustained demand for accurate three-dimensional protein structures, expanding access to synchrotron beamlines, improved crystallization screens, automation, microfocus X-ray sources, and complementary computational tools. The Protein Data Bank surpassed 200,000 experimentally determined structures in 2023, underscoring the scale of global structural biology output and the continued relevance of crystallographic methods alongside cryo-electron microscopy, NMR spectroscopy, and AI-based protein structure prediction.

Transformative Shifts in the Landscape

The protein crystallization and crystallography landscape is shifting from manual, low-throughput workflows toward automated, data-rich, and miniaturized platforms. Robotic liquid handlers, nanoliter dispensing, automated imaging systems, microfluidics, and improved crystallization kits are reducing sample consumption and increasing the probability of identifying usable crystal conditions for difficult protein targets.

At the same time, crystallography is becoming more integrated with cryo-EM, mass spectrometry, computational modeling, biophysical assays, and fragment screening. Pharmaceutical and biotechnology teams increasingly use crystallography not as a stand-alone technique but as part of an integrated structural biology pipeline that accelerates hit-to-lead decisions, resolves ligand binding modes, and improves confidence in drug-target interactions.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is reshaping protein crystallization and crystallography by improving target prioritization, construct design, crystallization-condition selection, diffraction-image analysis, molecular replacement, and model refinement. The AlphaFold Protein Structure Database, developed by DeepMind and EMBL-EBI, made more than 200 million predicted protein structures available, dramatically expanding the starting point for hypothesis generation and molecular replacement strategies.

However, AI has not replaced experimental crystallography. Predicted models require validation for ligand complexes, conformational states, post-translational modifications, solvent networks, metal coordination, and allosteric mechanisms. The cumulative impact of AI is therefore strongest when paired with experimental X-ray crystallography, where algorithms reduce cycle time while crystallographic data provide the empirical evidence needed for regulatory-grade and publication-grade structural conclusions.

Key Regional Insights

Asia-Pacific is advancing rapidly through investments in synchrotron infrastructure, pharmaceutical R&D, and structural biology capacity across China, Japan, India, South Korea, Australia, and ASEAN economies. Regional momentum is supported by large scientific workforces, expanding biologics and biosimilar programs, and facilities such as SPring-8 in Japan, the Shanghai Synchrotron Radiation Facility in China, the Pohang Accelerator Laboratory in South Korea, and the Australian Synchrotron. North America remains a leading region because of dense biopharmaceutical activity, NIH- and NSF-supported research, mature contract research organizations, and major synchrotron access in the United States and Canada, including the Advanced Photon Source, Stanford Synchrotron Radiation Lightsource, National Synchrotron Light Source II, and Canadian Light Source.

Europe benefits from coordinated research funding, pan-European infrastructure, and strong academic-industry collaboration across Germany, France, the United Kingdom, Italy, Spain, and the broader European Union, supported by facilities such as the European Synchrotron Radiation Facility, Diamond Light Source, PETRA III, SOLEIL, ALBA, and Elettra. Latin America is developing through research hubs in Brazil and Mexico, with Brazil's LNLS and Sirius synchrotron strengthening regional structural biology capabilities. The Middle East is gaining visibility through large science infrastructure, including SESAME in Jordan and GCC investments in life sciences, research universities, genomics, and biomedical innovation. Africa remains an emerging opportunity where capacity building, international collaborations, and infectious disease research are strengthening the long-term case for protein crystallization and X-ray crystallography adoption.

Key Group Insights

ASEAN is gaining relevance as Singapore, Thailand, Malaysia, Vietnam, Indonesia, and the Philippines expand biotechnology education, translational research, regional pharmaceutical manufacturing, and biomedical research partnerships. The GCC is positioning life sciences as part of economic diversification, with Saudi Arabia, the United Arab Emirates, and Qatar investing in research universities, genomics, health innovation, and biomedical infrastructure that can support future structural biology demand.

The European Union remains a strong force through Horizon Europe funding, shared research infrastructure, and established crystallography communities connected to major beamline networks and cross-border scientific programs. BRICS countries, particularly China, India, Brazil, and Russia, contribute through large scientific workforces, expanding domestic pharmaceutical activity, and government-supported research infrastructure. G7 countries continue to anchor advanced demand through mature drug discovery ecosystems, high-end instrumentation, and world-class synchrotron access, while NATO economies overlap heavily with established biomedical research ecosystems that emphasize secure supply chains, research continuity, and resilient scientific infrastructure.

Key Country Insights

The United States leads demand through biopharma R&D, federal research funding, national laboratories, and synchrotron facilities such as the Advanced Photon Source, Stanford Synchrotron Radiation Lightsource, National Synchrotron Light Source II, and Advanced Light Source. Canada contributes through academic structural biology networks, biotechnology clusters, and the Canadian Light Source, while Mexico is strengthening pharmaceutical manufacturing and university-led research. Brazil is Latin America's most prominent structural biology market, supported by LNLS and Sirius synchrotron capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain maintain strong crystallography ecosystems through universities, pharmaceutical research, national laboratories, and access to European beamlines, while Russia retains scientific capacity through established academic institutes despite constraints affecting international collaboration. China is scaling structural biology through domestic pharmaceutical innovation and major facilities including the Shanghai Synchrotron Radiation Facility; India is expanding through generics, biosimilars, vaccine research, and academic structural biology; Japan has long-standing crystallography excellence supported by advanced facilities such as SPring-8 and Photon Factory; Australia supports regional structural biology through the Australian Synchrotron and biomedical institutes; and South Korea is growing through biopharma, diagnostics, government-backed science programs, and synchrotron access at the Pohang Accelerator Laboratory.

Actionable Recommendations for Industry Leaders

Industry leaders should treat protein crystallization and crystallography as a strategic capability within integrated structural biology rather than a narrow laboratory service. Priority actions include automating crystallization screening, adopting AI-assisted construct and condition selection, improving laboratory data management, and combining X-ray crystallography with cryo-EM, biophysics, mass spectrometry, and computational chemistry.

Organizations should also secure reliable access to synchrotron beamlines, invest in staff capable of interpreting both experimental and AI-predicted models, and build partnerships with contract research organizations, academic centers, and public facilities. For drug discovery teams, the highest operational value comes from using crystallography early in hit validation and continuously during lead optimization to reduce uncertainty in binding mode, selectivity, and structure-activity relationships.

Research Methodology

This executive summary is developed using a structured secondary-research methodology focused on verified scientific, institutional, and industry sources. Evidence inputs include public resources from the Worldwide Protein Data Bank, RCSB PDB, EMBL-EBI, peer-reviewed structural biology literature, government R&D funding agencies, synchrotron facility publications, and established pharmaceutical and biotechnology disclosures.

Insights are triangulated across technology adoption trends, regional infrastructure, academic output, pharmaceutical R&D activity, and known developments in AI-driven protein structure prediction. The analysis avoids unsupported market-size, market-share, and forecasting claims and instead emphasizes observable indicators such as infrastructure investment, scientific publication activity, public databases, and documented platform advances.

Conclusion

Protein crystallization and crystallography continue to play a critical role in understanding protein function and enabling structure-based drug discovery. Even as AI prediction and cryo-EM expand the structural biology toolkit, crystallography remains essential for experimentally validating atomic detail, ligand binding, solvent interactions, metal coordination, and conformational states.

The strongest opportunities will emerge for organizations that combine automation, AI, high-quality experimental design, and global infrastructure access. As biopharmaceutical pipelines become more complex and precision medicine advances, reliable protein crystallization and X-ray crystallography capabilities will remain central to competitive research and development.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Protein Crystallization & Crystallography Market, by Product Type

  • 7.1. Instruments
    • 7.1.1. Protein Crystallization Instruments
      • 7.1.1.1. Liquid Handling Systems
      • 7.1.1.1.1. Nanoliter Dispensing Systems
      • 7.1.1.1.2. Microfluidic Liquid Handlers
      • 7.1.1.2. Imaging Systems
      • 7.1.1.3. Incubators
    • 7.1.2. Crystallography Instruments
      • 7.1.2.1. X-ray Diffractometers
      • 7.1.2.2. Cryo-electron Microscopy Systems
      • 7.1.2.3. Beamline Instruments
      • 7.1.2.3.1. Synchrotron Beamlines
      • 7.1.2.3.2. Microfocus Beamlines
  • 7.2. Consumables
    • 7.2.1. Crystallization Reagents
      • 7.2.1.1. Buffers
      • 7.2.1.2. Precipitants
      • 7.2.1.3. Additives
    • 7.2.2. Crystallization Kits
    • 7.2.3. Plates
      • 7.2.3.1. 24-well Plates
      • 7.2.3.2. 96-well Plates
      • 7.2.3.3. 384-well Plates
    • 7.2.4. Sealing Systems
  • 7.3. Software
    • 7.3.1. Data Collection Software
    • 7.3.2. Visualization Software
    • 7.3.3. Data Processing Software
  • 7.4. Services
    • 7.4.1. Protein Crystallization Services
      • 7.4.1.1. Screening Services
      • 7.4.1.2. Optimization Services
    • 7.4.2. Structure Determination Services
      • 7.4.2.1. X-ray Crystallography Services
      • 7.4.2.2. Cryo-EM Services
    • 7.4.3. Consulting Services

8. Protein Crystallization & Crystallography Market, by Technology

  • 8.1. Electron Crystallography
  • 8.2. Neutron Crystallography

9. Protein Crystallization & Crystallography Market, by Crystal Type

  • 9.1. Soluble Protein Crystals
  • 9.2. Membrane Protein Crystals
  • 9.3. Protein Complex Crystals
  • 9.4. Nucleic Acid Complex Crystals

10. Protein Crystallization & Crystallography Market, by Application

  • 10.1. Drug Discovery & Development
    • 10.1.1. Structure-based Drug Design
    • 10.1.2. Fragment-based Drug Discovery
    • 10.1.3. Lead Optimization
  • 10.2. Materials Science
  • 10.3. Structural Biology

11. Protein Crystallization & Crystallography Market, by End User

  • 11.1. Academic & Research Institutes
  • 11.2. Contract Research Organizations
  • 11.3. Pharmaceutical & Biotechnology Companies

12. Protein Crystallization & Crystallography Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Protein Crystallization & Crystallography Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Protein Crystallization & Crystallography Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Agilent Technologies Inc
  • 16.2. Anton Paar GmbH
  • 16.3. Arinax Scientific Instrumentation
  • 16.4. Art Robbins Instruments LLC
  • 16.5. Bio Rad Laboratories Inc
  • 16.6. BOC Sciences
  • 16.7. Bruker Corporation
  • 16.8. Calibre Scientific Inc
  • 16.9. Charles River Laboratories International Inc
  • 16.10. Corning Incorporated
  • 16.11. Creative Biostructure
  • 16.12. Danaher Corporation
  • 16.13. Douglas Instruments Ltd
  • 16.14. Emerald Biosystems Inc
  • 16.15. Formulatrix Inc
  • 16.16. Greiner Bio One International GmbH
  • 16.17. Hampton Research Corp
  • 16.18. Helix BioStructures LLC
  • 16.19. HiMedia Laboratories Pvt Ltd
  • 16.20. Jena Bioscience GmbH
  • 16.21. Merck KGaA
  • 16.22. Mettler Toledo International Inc
  • 16.23. MiTeGen LLC
  • 16.24. Molecular Dimensions Ltd
  • 16.25. Proteros Biostructures GmbH
  • 16.26. QIAGEN GmbH
  • 16.27. Rigaku Holdings Corporation
  • 16.28. SARomics Biostructures AB
  • 16.29. Tecan Group Ltd
  • 16.30. Thermo Fisher Scientific Inc

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PROTEIN CRYSTALLIZATION INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PROTEIN CRYSTALLIZATION INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PROTEIN CRYSTALLIZATION INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LIQUID HANDLING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL NANOLITER DISPENSING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL NANOLITER DISPENSING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL NANOLITER DISPENSING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MICROFLUIDIC LIQUID HANDLERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MICROFLUIDIC LIQUID HANDLERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MICROFLUIDIC LIQUID HANDLERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMAGING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INCUBATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INCUBATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INCUBATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CRYSTALLOGRAPHY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CRYSTALLOGRAPHY INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CRYSTALLOGRAPHY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL X-RAY DIFFRACTOMETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL X-RAY DIFFRACTOMETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL X-RAY DIFFRACTOMETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CRYO-ELECTRON MICROSCOPY SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CRYO-ELECTRON MICROSCOPY SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CRYO-ELECTRON MICROSCOPY SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BEAMLINE INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BEAMLINE INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BEAMLINE INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SYNCHROTRON BEAMLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SYNCHROTRON BEAMLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SYNCHROTRON BEAMLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL MICROFOCUS BEAMLINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL MICROFOCUS BEAMLINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL MICROFOCUS BEAMLINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CONSUMABLES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONSUMABLES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CONSUMABLES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CRYSTALLIZATION REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CRYSTALLIZATION REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CRYSTALLIZATION REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BUFFERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BUFFERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BUFFERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PRECIPITANTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PRECIPITANTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PRECIPITANTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ADDITIVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ADDITIVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ADDITIVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CRYSTALLIZATION KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CRYSTALLIZATION KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CRYSTALLIZATION KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL 24-WELL PLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL 24-WELL PLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL 24-WELL PLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL 96-WELL PLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL 96-WELL PLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL 96-WELL PLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL 384-WELL PLATES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL 384-WELL PLATES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL 384-WELL PLATES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SEALING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SEALING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SEALING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL DATA COLLECTION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DATA COLLECTION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DATA COLLECTION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VISUALIZATION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VISUALIZATION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VISUALIZATION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL DATA PROCESSING SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL DATA PROCESSING SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL DATA PROCESSING SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PROTEIN CRYSTALLIZATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROTEIN CRYSTALLIZATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROTEIN CRYSTALLIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SCREENING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SCREENING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SCREENING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL OPTIMIZATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL OPTIMIZATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL OPTIMIZATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL STRUCTURE DETERMINATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL STRUCTURE DETERMINATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL STRUCTURE DETERMINATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL X-RAY CRYSTALLOGRAPHY SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL X-RAY CRYSTALLOGRAPHY SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL X-RAY CRYSTALLOGRAPHY SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CRYO-EM SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CRYO-EM SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CRYO-EM SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ELECTRON CRYSTALLOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ELECTRON CRYSTALLOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ELECTRON CRYSTALLOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL NEUTRON CRYSTALLOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL NEUTRON CRYSTALLOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL NEUTRON CRYSTALLOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL SOLUBLE PROTEIN CRYSTALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL SOLUBLE PROTEIN CRYSTALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL SOLUBLE PROTEIN CRYSTALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MEMBRANE PROTEIN CRYSTALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MEMBRANE PROTEIN CRYSTALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL MEMBRANE PROTEIN CRYSTALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL PROTEIN COMPLEX CRYSTALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL PROTEIN COMPLEX CRYSTALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PROTEIN COMPLEX CRYSTALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NUCLEIC ACID COMPLEX CRYSTALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NUCLEIC ACID COMPLEX CRYSTALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NUCLEIC ACID COMPLEX CRYSTALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL DRUG DISCOVERY & DEVELOPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL STRUCTURE-BASED DRUG DESIGN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL STRUCTURE-BASED DRUG DESIGN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL STRUCTURE-BASED DRUG DESIGN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL LEAD OPTIMIZATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL MATERIALS SCIENCE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL MATERIALS SCIENCE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL MATERIALS SCIENCE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL STRUCTURAL BIOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL STRUCTURAL BIOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL STRUCTURAL BIOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 179. ASIA-PACIFIC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 180. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 188. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 190. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 200. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 202. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 204. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 218. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 219. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 240. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 242. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 244. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 246. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 257. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 259. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 260. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 261. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 262. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 263. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 264. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 265. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 277. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 279. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 280. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 281. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 282. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 284. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 285. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 286. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 287. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 288. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 289. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 290. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 291. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 294. ASEAN PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 295. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 297. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 298. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 299. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY LIQUID HANDLING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 300. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLOGRAPHY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 301. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY BEAMLINE INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 302. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 303. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTALLIZATION REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 304. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PLATES, 2018-2032 (USD MILLION)
  • TABLE 305. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 306. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 307. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY PROTEIN CRYSTALLIZATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 308. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY STRUCTURE DETERMINATION SERVICES, 2018-2032 (USD MILLION)
  • TABLE 309. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 310. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY CRYSTAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 312. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2032 (USD MILLION)
  • TABLE 313. GCC PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 314. EUROPEAN UNION PROTEIN CRYSTALLIZATION & CRYSTALLOGRAPHY MARKET SIZE, 2018-2032 (USD MILLION)

T